| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reoviridae Infections | 42 | 2019 | 54 | 7.690 |
Why?
|
| Enterovirus D, Human | 17 | 2026 | 87 | 6.930 |
Why?
|
| West Nile Fever | 23 | 2023 | 57 | 6.710 |
Why?
|
| Enterovirus Infections | 17 | 2026 | 173 | 6.180 |
Why?
|
| Central Nervous System Viral Diseases | 20 | 2025 | 78 | 5.890 |
Why?
|
| Myelitis | 25 | 2026 | 107 | 5.780 |
Why?
|
| Encephalitis, Viral | 25 | 2021 | 45 | 5.640 |
Why?
|
| West Nile virus | 18 | 2023 | 41 | 5.520 |
Why?
|
| Reoviridae | 29 | 2019 | 38 | 4.540 |
Why?
|
| Apoptosis | 51 | 2021 | 2434 | 3.910 |
Why?
|
| Mammalian orthoreovirus 3 | 32 | 2019 | 38 | 3.810 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 15 | 2019 | 38 | 3.810 |
Why?
|
| Neuromuscular Diseases | 13 | 2025 | 145 | 3.610 |
Why?
|
| Nervous System Diseases | 15 | 2020 | 286 | 3.250 |
Why?
|
| Antiviral Agents | 21 | 2026 | 767 | 2.930 |
Why?
|
| Brain | 38 | 2023 | 2934 | 2.890 |
Why?
|
| Paralysis | 12 | 2025 | 69 | 2.870 |
Why?
|
| Central Nervous System Infections | 7 | 2022 | 35 | 2.010 |
Why?
|
| Capsid Proteins | 11 | 2026 | 92 | 1.920 |
Why?
|
| Neurology | 12 | 2017 | 116 | 1.920 |
Why?
|
| Zika Virus Infection | 5 | 2017 | 172 | 1.780 |
Why?
|
| Encephalitis, Herpes Simplex | 9 | 2020 | 21 | 1.750 |
Why?
|
| Encephalitis | 8 | 2022 | 142 | 1.660 |
Why?
|
| Acyclovir | 9 | 2020 | 97 | 1.660 |
Why?
|
| Neurons | 23 | 2022 | 1644 | 1.630 |
Why?
|
| Mice | 81 | 2026 | 18303 | 1.580 |
Why?
|
| Animals | 115 | 2026 | 37952 | 1.510 |
Why?
|
| Host-Pathogen Interactions | 5 | 2021 | 361 | 1.490 |
Why?
|
| Disease Models, Animal | 18 | 2026 | 4552 | 1.410 |
Why?
|
| Microglia | 7 | 2023 | 270 | 1.370 |
Why?
|
| Simplexvirus | 13 | 2020 | 82 | 1.300 |
Why?
|
| Spinal Cord | 9 | 2024 | 382 | 1.290 |
Why?
|
| Meningoencephalitis | 6 | 2021 | 24 | 1.290 |
Why?
|
| Central Nervous System Diseases | 6 | 2023 | 74 | 1.280 |
Why?
|
| Multiple Sclerosis | 5 | 2022 | 487 | 1.240 |
Why?
|
| Polymerase Chain Reaction | 18 | 2018 | 1039 | 1.200 |
Why?
|
| Herpes Simplex | 7 | 2021 | 98 | 1.170 |
Why?
|
| Viral Load | 7 | 2023 | 525 | 1.140 |
Why?
|
| Communicable Diseases, Emerging | 4 | 2016 | 39 | 1.130 |
Why?
|
| Zika Virus | 4 | 2017 | 136 | 1.120 |
Why?
|
| Central Nervous System | 11 | 2017 | 281 | 1.110 |
Why?
|
| Cell Death | 4 | 2022 | 382 | 1.080 |
Why?
|
| Humans | 168 | 2026 | 145140 | 1.070 |
Why?
|
| Antibodies, Viral | 8 | 2025 | 673 | 1.060 |
Why?
|
| Herpesviridae Infections | 6 | 2013 | 148 | 1.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2022 | 530 | 1.020 |
Why?
|
| Epstein-Barr Virus Infections | 3 | 2022 | 101 | 1.020 |
Why?
|
| Disease Outbreaks | 7 | 2022 | 419 | 1.010 |
Why?
|
| Motor Neurons | 4 | 2024 | 236 | 1.000 |
Why?
|
| Meningitis, Viral | 8 | 2020 | 20 | 1.000 |
Why?
|
| Antibodies, Monoclonal | 12 | 2025 | 1505 | 0.990 |
Why?
|
| Orthoreovirus, Mammalian | 5 | 2011 | 7 | 0.980 |
Why?
|
| Caspases | 12 | 2013 | 233 | 0.970 |
Why?
|
| Virus Replication | 20 | 2025 | 519 | 0.960 |
Why?
|
| Interferon-beta | 4 | 2019 | 92 | 0.930 |
Why?
|
| JC Virus | 8 | 2015 | 23 | 0.920 |
Why?
|
| Meningitis | 4 | 2023 | 80 | 0.900 |
Why?
|
| Arbovirus Infections | 3 | 2019 | 20 | 0.880 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 388 | 0.870 |
Why?
|
| Caspase 3 | 9 | 2023 | 242 | 0.870 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 382 | 0.870 |
Why?
|
| Monkeypox virus | 3 | 2023 | 23 | 0.830 |
Why?
|
| Cytokines | 9 | 2022 | 2048 | 0.820 |
Why?
|
| Herpesvirus 1, Human | 3 | 2021 | 84 | 0.810 |
Why?
|
| Signal Transduction | 19 | 2019 | 5208 | 0.810 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 5 | 2007 | 19 | 0.800 |
Why?
|
| Virion | 3 | 2022 | 108 | 0.790 |
Why?
|
| Guillain-Barre Syndrome | 3 | 2020 | 23 | 0.780 |
Why?
|
| Viral Proteins | 11 | 2025 | 350 | 0.770 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2023 | 161 | 0.760 |
Why?
|
| Natalizumab | 4 | 2019 | 41 | 0.750 |
Why?
|
| Minocycline | 2 | 2017 | 23 | 0.750 |
Why?
|
| Dog Diseases | 2 | 2021 | 70 | 0.750 |
Why?
|
| Caspase Inhibitors | 6 | 2011 | 81 | 0.710 |
Why?
|
| Virus Diseases | 7 | 2009 | 216 | 0.710 |
Why?
|
| Astrocytes | 5 | 2019 | 228 | 0.700 |
Why?
|
| Spine | 2 | 2017 | 181 | 0.700 |
Why?
|
| Fluoxetine | 3 | 2018 | 56 | 0.690 |
Why?
|
| Cell Line | 21 | 2022 | 2821 | 0.690 |
Why?
|
| Meningitis, Bacterial | 4 | 2010 | 46 | 0.680 |
Why?
|
| Immunity, Innate | 5 | 2021 | 834 | 0.680 |
Why?
|
| Sexual and Gender Minorities | 2 | 2022 | 259 | 0.680 |
Why?
|
| Capsid | 7 | 2026 | 93 | 0.670 |
Why?
|
| Carrier Proteins | 8 | 2013 | 728 | 0.650 |
Why?
|
| Exosomes | 1 | 2022 | 104 | 0.650 |
Why?
|
| Animals, Newborn | 13 | 2026 | 891 | 0.640 |
Why?
|
| Betacoronavirus | 2 | 2020 | 287 | 0.640 |
Why?
|
| Encephalitis, California | 2 | 2019 | 9 | 0.620 |
Why?
|
| Encephalitis, Tick-Borne | 2 | 2019 | 8 | 0.620 |
Why?
|
| Hashimoto Disease | 1 | 2019 | 10 | 0.610 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2019 | 16 | 0.600 |
Why?
|
| Axonal Transport | 1 | 2019 | 26 | 0.600 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 6 | 2009 | 153 | 0.590 |
Why?
|
| Immune System | 2 | 2020 | 177 | 0.590 |
Why?
|
| Zoonoses | 2 | 2009 | 37 | 0.590 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 209 | 0.580 |
Why?
|
| Immunosuppressive Agents | 3 | 2015 | 837 | 0.570 |
Why?
|
| Orthoreovirus | 5 | 1998 | 5 | 0.570 |
Why?
|
| Encephalitis, Japanese | 1 | 2018 | 3 | 0.570 |
Why?
|
| Critical Care | 2 | 2017 | 702 | 0.560 |
Why?
|
| Enzyme Inhibitors | 4 | 2011 | 820 | 0.530 |
Why?
|
| Herpes Zoster | 2 | 2015 | 318 | 0.520 |
Why?
|
| Prion Diseases | 3 | 2008 | 15 | 0.520 |
Why?
|
| Neurosyphilis | 2 | 2013 | 3 | 0.510 |
Why?
|
| Hepatitis E | 1 | 2017 | 2 | 0.510 |
Why?
|
| Hepatitis E virus | 1 | 2017 | 2 | 0.510 |
Why?
|
| Plasma Exchange | 1 | 2017 | 18 | 0.510 |
Why?
|
| NF-kappa B | 7 | 2010 | 664 | 0.500 |
Why?
|
| Herpesvirus 3, Human | 3 | 2015 | 341 | 0.500 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2016 | 14 | 0.490 |
Why?
|
| Myocarditis | 5 | 2009 | 102 | 0.490 |
Why?
|
| Macrophage Activation | 1 | 2017 | 181 | 0.490 |
Why?
|
| Virology | 1 | 2016 | 36 | 0.480 |
Why?
|
| Prions | 3 | 2008 | 50 | 0.470 |
Why?
|
| Antibodies, Neutralizing | 4 | 2025 | 340 | 0.470 |
Why?
|
| Caspase 8 | 8 | 2013 | 47 | 0.460 |
Why?
|
| Immunocompromised Host | 5 | 2009 | 202 | 0.460 |
Why?
|
| Viruses | 6 | 2009 | 164 | 0.450 |
Why?
|
| Gene Expression Regulation | 6 | 2010 | 2588 | 0.450 |
Why?
|
| Thrombocytopenia | 1 | 2017 | 204 | 0.440 |
Why?
|
| Mitochondria | 8 | 2016 | 992 | 0.440 |
Why?
|
| Toll-Like Receptor 3 | 2 | 2014 | 30 | 0.440 |
Why?
|
| History, 20th Century | 10 | 2016 | 327 | 0.440 |
Why?
|
| Cerebrospinal Fluid | 7 | 2005 | 88 | 0.440 |
Why?
|
| Chikungunya Fever | 1 | 2016 | 82 | 0.440 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2003 | 1216 | 0.430 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 6 | 2007 | 54 | 0.430 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 629 | 0.430 |
Why?
|
| Valine | 1 | 2015 | 82 | 0.430 |
Why?
|
| Propylene Glycols | 1 | 2015 | 28 | 0.430 |
Why?
|
| Medication Reconciliation | 1 | 2015 | 32 | 0.430 |
Why?
|
| Membrane Glycoproteins | 6 | 2004 | 499 | 0.430 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2017 | 477 | 0.430 |
Why?
|
| Sphingosine | 1 | 2015 | 45 | 0.430 |
Why?
|
| Glial Fibrillary Acidic Protein | 5 | 2021 | 122 | 0.430 |
Why?
|
| Neuroglia | 4 | 2012 | 173 | 0.420 |
Why?
|
| Calpain | 4 | 2008 | 61 | 0.420 |
Why?
|
| Encephalitis Viruses, Japanese | 1 | 2014 | 1 | 0.420 |
Why?
|
| Leukoencephalitis, Acute Hemorrhagic | 2 | 2020 | 5 | 0.420 |
Why?
|
| Receptors, Tumor Necrosis Factor | 4 | 2002 | 161 | 0.420 |
Why?
|
| Encephalitis, St. Louis | 1 | 2014 | 2 | 0.410 |
Why?
|
| Encephalitis Virus, St. Louis | 1 | 2014 | 3 | 0.410 |
Why?
|
| Nervous System | 2 | 2007 | 69 | 0.410 |
Why?
|
| PrPSc Proteins | 2 | 2004 | 8 | 0.410 |
Why?
|
| Drug Discovery | 1 | 2015 | 153 | 0.410 |
Why?
|
| Receptors, Death Domain | 1 | 2013 | 4 | 0.410 |
Why?
|
| Peripheral Nervous System | 1 | 2013 | 20 | 0.400 |
Why?
|
| Interferon Type I | 2 | 2013 | 147 | 0.400 |
Why?
|
| Caspase 9 | 7 | 2013 | 55 | 0.400 |
Why?
|
| Heart | 3 | 2011 | 626 | 0.390 |
Why?
|
| Mitochondrial Proteins | 3 | 2005 | 263 | 0.390 |
Why?
|
| Enzyme Activation | 5 | 2010 | 762 | 0.390 |
Why?
|
| Penicillins | 1 | 2013 | 62 | 0.380 |
Why?
|
| Viral Nonstructural Proteins | 2 | 2005 | 63 | 0.380 |
Why?
|
| Epidemics | 1 | 2014 | 96 | 0.380 |
Why?
|
| Virulence | 7 | 2024 | 278 | 0.370 |
Why?
|
| Phagocytosis | 1 | 2014 | 296 | 0.370 |
Why?
|
| Male | 51 | 2026 | 72664 | 0.370 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 532 | 0.360 |
Why?
|
| Enterovirus | 3 | 2023 | 83 | 0.360 |
Why?
|
| Acute Disease | 6 | 2018 | 1035 | 0.360 |
Why?
|
| DNA, Viral | 8 | 2003 | 355 | 0.360 |
Why?
|
| Receptor, Interferon alpha-beta | 2 | 2012 | 35 | 0.360 |
Why?
|
| STAT1 Transcription Factor | 3 | 2012 | 66 | 0.350 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 2 | 2011 | 95 | 0.350 |
Why?
|
| Female | 46 | 2026 | 78636 | 0.350 |
Why?
|
| Cytomegalovirus Infections | 2 | 2004 | 206 | 0.350 |
Why?
|
| Brain Diseases | 3 | 2020 | 154 | 0.340 |
Why?
|
| Apoptosis Regulatory Proteins | 9 | 2005 | 187 | 0.340 |
Why?
|
| Cells, Cultured | 14 | 2013 | 4142 | 0.340 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 53 | 0.330 |
Why?
|
| Immunoglobulins, Intravenous | 3 | 2019 | 133 | 0.330 |
Why?
|
| Chemokines | 2 | 2022 | 217 | 0.330 |
Why?
|
| fas Receptor | 2 | 2009 | 91 | 0.320 |
Why?
|
| Gene Expression Profiling | 3 | 2014 | 1763 | 0.320 |
Why?
|
| Genes, Viral | 9 | 1998 | 88 | 0.320 |
Why?
|
| History, 19th Century | 10 | 2010 | 63 | 0.320 |
Why?
|
| Cysteine Proteinase Inhibitors | 3 | 2001 | 49 | 0.320 |
Why?
|
| Virus Internalization | 2 | 2022 | 65 | 0.310 |
Why?
|
| Cell Cycle | 3 | 2002 | 596 | 0.310 |
Why?
|
| HeLa Cells | 8 | 2018 | 631 | 0.310 |
Why?
|
| United States | 13 | 2023 | 16065 | 0.310 |
Why?
|
| Up-Regulation | 5 | 2016 | 846 | 0.310 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 2 | 2007 | 20 | 0.310 |
Why?
|
| Flavivirus Infections | 2 | 2019 | 9 | 0.310 |
Why?
|
| Disease Progression | 8 | 2025 | 2857 | 0.310 |
Why?
|
| Macrophages | 1 | 2017 | 1500 | 0.300 |
Why?
|
| Immunomodulation | 1 | 2010 | 99 | 0.300 |
Why?
|
| Neuroprotective Agents | 1 | 2011 | 147 | 0.300 |
Why?
|
| Cerebellum | 3 | 2012 | 224 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-jun | 3 | 2005 | 54 | 0.280 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2009 | 142 | 0.280 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2009 | 82 | 0.270 |
Why?
|
| Discitis | 1 | 2008 | 3 | 0.270 |
Why?
|
| Motor Neuron Disease | 1 | 2008 | 20 | 0.270 |
Why?
|
| Bone Diseases, Infectious | 1 | 2008 | 8 | 0.270 |
Why?
|
| Spinal Cord Diseases | 1 | 2008 | 42 | 0.270 |
Why?
|
| Bell Palsy | 1 | 2007 | 9 | 0.270 |
Why?
|
| Herpesvirus 4, Human | 3 | 2022 | 172 | 0.260 |
Why?
|
| Prednisolone | 1 | 2007 | 67 | 0.260 |
Why?
|
| Back Pain | 1 | 2008 | 52 | 0.260 |
Why?
|
| Janus Kinases | 1 | 2007 | 21 | 0.260 |
Why?
|
| Cytomegalovirus | 2 | 2004 | 168 | 0.250 |
Why?
|
| Rituximab | 3 | 2021 | 210 | 0.250 |
Why?
|
| Kuru | 2 | 2004 | 2 | 0.250 |
Why?
|
| Wasting Disease, Chronic | 1 | 2007 | 27 | 0.250 |
Why?
|
| RNA, Viral | 6 | 2004 | 690 | 0.250 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2013 | 456 | 0.250 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2012 | 194 | 0.240 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2007 | 76 | 0.240 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 474 | 0.240 |
Why?
|
| Receptors, Virus | 3 | 2005 | 95 | 0.240 |
Why?
|
| Child, Preschool | 11 | 2022 | 11835 | 0.240 |
Why?
|
| Health Services Needs and Demand | 1 | 2008 | 279 | 0.240 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 4 | 2009 | 11 | 0.240 |
Why?
|
| Adult | 28 | 2022 | 40665 | 0.230 |
Why?
|
| Child | 17 | 2022 | 22670 | 0.230 |
Why?
|
| Cytochromes c | 2 | 2005 | 53 | 0.230 |
Why?
|
| HIV Infections | 3 | 2013 | 3186 | 0.230 |
Why?
|
| Integrin alpha4 | 1 | 2005 | 7 | 0.230 |
Why?
|
| Homosexuality, Male | 3 | 2022 | 231 | 0.230 |
Why?
|
| Viral Tropism | 2 | 2018 | 36 | 0.230 |
Why?
|
| Dogs | 4 | 2021 | 438 | 0.220 |
Why?
|
| Encephalomyelitis, Eastern Equine | 2 | 2019 | 5 | 0.220 |
Why?
|
| Opportunistic Infections | 1 | 2005 | 47 | 0.220 |
Why?
|
| Transcription Factors | 2 | 2005 | 1731 | 0.220 |
Why?
|
| Feces | 1 | 2008 | 494 | 0.220 |
Why?
|
| Health Surveys | 1 | 2007 | 517 | 0.220 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 234 | 0.220 |
Why?
|
| Scrapie | 1 | 2004 | 3 | 0.210 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2003 | 237 | 0.210 |
Why?
|
| Mice, Knockout | 7 | 2012 | 3114 | 0.210 |
Why?
|
| History, 21st Century | 3 | 2016 | 220 | 0.210 |
Why?
|
| Recombinant Proteins | 3 | 2023 | 1368 | 0.210 |
Why?
|
| Immunologic Factors | 2 | 2021 | 260 | 0.210 |
Why?
|
| Blotting, Western | 5 | 2010 | 1177 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2023 | 3892 | 0.200 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2004 | 117 | 0.200 |
Why?
|
| Cell Nucleus | 2 | 2004 | 587 | 0.200 |
Why?
|
| Oligodendroglia | 2 | 2003 | 190 | 0.200 |
Why?
|
| Adjuvants, Immunologic | 1 | 2005 | 243 | 0.200 |
Why?
|
| Hand, Foot and Mouth Disease | 1 | 2023 | 3 | 0.200 |
Why?
|
| Drug Design | 3 | 2026 | 175 | 0.200 |
Why?
|
| Medical Tourism | 1 | 2023 | 9 | 0.200 |
Why?
|
| Encephalomyelitis, Acute Disseminated | 2 | 2020 | 11 | 0.200 |
Why?
|
| Roseolovirus Infections | 1 | 2003 | 8 | 0.200 |
Why?
|
| Arthropod Vectors | 2 | 2016 | 7 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2001 | 288 | 0.190 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2017 | 162 | 0.190 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 1713 | 0.190 |
Why?
|
| Herpesvirus 6, Human | 1 | 2003 | 14 | 0.190 |
Why?
|
| Antigens, Viral | 4 | 2009 | 182 | 0.190 |
Why?
|
| Glucocorticoids | 1 | 2007 | 531 | 0.190 |
Why?
|
| Neutralization Tests | 4 | 2017 | 76 | 0.190 |
Why?
|
| Reassortant Viruses | 3 | 2005 | 8 | 0.190 |
Why?
|
| Age of Onset | 1 | 2005 | 554 | 0.190 |
Why?
|
| Immunization, Passive | 3 | 1993 | 90 | 0.190 |
Why?
|
| Middle Aged | 25 | 2019 | 36126 | 0.190 |
Why?
|
| Olfactory Mucosa | 1 | 2003 | 39 | 0.190 |
Why?
|
| Flavivirus | 2 | 2019 | 19 | 0.190 |
Why?
|
| Encephalomyelitis | 1 | 2022 | 14 | 0.190 |
Why?
|
| Organ Culture Techniques | 2 | 2014 | 154 | 0.180 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2003 | 93 | 0.180 |
Why?
|
| Poliomyelitis | 1 | 2022 | 35 | 0.180 |
Why?
|
| Eukaryotic Cells | 1 | 2002 | 35 | 0.180 |
Why?
|
| Survival Analysis | 3 | 2018 | 1371 | 0.180 |
Why?
|
| Poliovirus | 1 | 2022 | 73 | 0.180 |
Why?
|
| Densitometry | 1 | 2022 | 36 | 0.180 |
Why?
|
| Treatment Outcome | 8 | 2019 | 11741 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2007 | 239 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 4 | 2017 | 776 | 0.180 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2011 | 1174 | 0.180 |
Why?
|
| Cell Adhesion Molecules | 2 | 2019 | 181 | 0.180 |
Why?
|
| Exanthema | 1 | 2022 | 86 | 0.180 |
Why?
|
| Mycobacterium abscessus | 1 | 2023 | 110 | 0.170 |
Why?
|
| CDC2 Protein Kinase | 1 | 2001 | 27 | 0.170 |
Why?
|
| Nervous System Malformations | 1 | 2022 | 46 | 0.170 |
Why?
|
| Pandemics | 2 | 2020 | 1703 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2003 | 977 | 0.170 |
Why?
|
| Enterovirus A, Human | 1 | 2021 | 13 | 0.170 |
Why?
|
| Oligopeptides | 1 | 2023 | 266 | 0.170 |
Why?
|
| Organ Transplantation | 1 | 2004 | 250 | 0.170 |
Why?
|
| Peptides | 1 | 2007 | 997 | 0.170 |
Why?
|
| DNA Repair | 1 | 2003 | 254 | 0.160 |
Why?
|
| Antibodies, Monoclonal, Humanized | 4 | 2017 | 992 | 0.160 |
Why?
|
| Stroke | 2 | 2020 | 1270 | 0.160 |
Why?
|
| Dipeptides | 1 | 2001 | 56 | 0.160 |
Why?
|
| Interferons | 2 | 2014 | 186 | 0.160 |
Why?
|
| G2 Phase | 1 | 2000 | 39 | 0.160 |
Why?
|
| Manuscripts, Medical as Topic | 1 | 2000 | 5 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 5 | 2022 | 1922 | 0.160 |
Why?
|
| Ovarian Neoplasms | 1 | 2007 | 594 | 0.160 |
Why?
|
| DNA-Directed DNA Polymerase | 2 | 1998 | 48 | 0.160 |
Why?
|
| Herpes Zoster Ophthalmicus | 1 | 2020 | 6 | 0.160 |
Why?
|
| Pigmentation Disorders | 1 | 2020 | 8 | 0.160 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2020 | 33 | 0.160 |
Why?
|
| Anti-Infective Agents | 2 | 2022 | 232 | 0.160 |
Why?
|
| Encephalitis Virus, California | 2 | 2019 | 6 | 0.160 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2020 | 25 | 0.160 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 2881 | 0.160 |
Why?
|
| Ophthalmoplegia | 1 | 1999 | 13 | 0.150 |
Why?
|
| Central Nervous System Bacterial Infections | 1 | 1999 | 5 | 0.150 |
Why?
|
| Facial Paralysis | 1 | 1999 | 23 | 0.150 |
Why?
|
| Thrombophilia | 1 | 2020 | 89 | 0.150 |
Why?
|
| Pons | 1 | 1999 | 33 | 0.150 |
Why?
|
| Immunoglobulin G | 3 | 2019 | 887 | 0.150 |
Why?
|
| Craniofacial Abnormalities | 1 | 2020 | 78 | 0.150 |
Why?
|
| Genes, pol | 2 | 1998 | 7 | 0.150 |
Why?
|
| Olfaction Disorders | 1 | 2020 | 70 | 0.150 |
Why?
|
| Proteins | 2 | 2002 | 1022 | 0.150 |
Why?
|
| Nerve Degeneration | 2 | 2011 | 49 | 0.150 |
Why?
|
| Bunyaviridae Infections | 1 | 2019 | 15 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2012 | 425 | 0.150 |
Why?
|
| Mitosis | 1 | 2000 | 193 | 0.150 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 106 | 0.150 |
Why?
|
| Myelitis, Transverse | 1 | 2019 | 4 | 0.150 |
Why?
|
| Gliosis | 1 | 2019 | 30 | 0.150 |
Why?
|
| Inflammation | 3 | 2020 | 2876 | 0.150 |
Why?
|
| North America | 2 | 2019 | 301 | 0.150 |
Why?
|
| Time Factors | 9 | 2008 | 7107 | 0.150 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 3 | 2004 | 18 | 0.140 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2019 | 55 | 0.140 |
Why?
|
| Writing | 1 | 2000 | 101 | 0.140 |
Why?
|
| rho-Associated Kinases | 1 | 2019 | 82 | 0.140 |
Why?
|
| Encephalitis Virus, Japanese | 1 | 2018 | 2 | 0.140 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2023 | 339 | 0.140 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 17 | 0.140 |
Why?
|
| Choledochal Cyst | 1 | 1998 | 17 | 0.140 |
Why?
|
| Abnormalities, Multiple | 1 | 2020 | 197 | 0.140 |
Why?
|
| Interferon-alpha | 2 | 2011 | 193 | 0.140 |
Why?
|
| Organ Specificity | 2 | 2013 | 308 | 0.140 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1998 | 16 | 0.140 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 156 | 0.130 |
Why?
|
| Tissue Culture Techniques | 2 | 2021 | 82 | 0.130 |
Why?
|
| Hybridomas | 2 | 1995 | 233 | 0.130 |
Why?
|
| Mental Disorders | 1 | 2007 | 1154 | 0.130 |
Why?
|
| Skin | 1 | 2022 | 753 | 0.130 |
Why?
|
| Neurogenesis | 1 | 2019 | 157 | 0.130 |
Why?
|
| Brazil | 1 | 2017 | 179 | 0.130 |
Why?
|
| Autoantibodies | 3 | 2021 | 1508 | 0.130 |
Why?
|
| Neuromyelitis Optica | 1 | 2019 | 140 | 0.130 |
Why?
|
| Cranial Nerve Diseases | 1 | 2017 | 44 | 0.130 |
Why?
|
| Dexamethasone | 2 | 2017 | 365 | 0.120 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 135 | 0.120 |
Why?
|
| Memory Disorders | 2 | 2016 | 197 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2000 | 352 | 0.120 |
Why?
|
| Muscular Diseases | 1 | 2017 | 107 | 0.120 |
Why?
|
| Movement Disorders | 1 | 2017 | 69 | 0.120 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2017 | 155 | 0.120 |
Why?
|
| Biliary Atresia | 1 | 1998 | 158 | 0.120 |
Why?
|
| Brain Ischemia | 1 | 2020 | 359 | 0.120 |
Why?
|
| Disease Vectors | 2 | 2009 | 15 | 0.120 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 272 | 0.120 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 221 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2005 | 2026 | 0.120 |
Why?
|
| Encephalitis Viruses, Tick-Borne | 1 | 2016 | 8 | 0.120 |
Why?
|
| Encephalopathy, Bovine Spongiform | 1 | 1995 | 4 | 0.120 |
Why?
|
| Culicidae | 1 | 2016 | 33 | 0.120 |
Why?
|
| Ticks | 1 | 2016 | 30 | 0.120 |
Why?
|
| Protein Interaction Mapping | 1 | 2016 | 105 | 0.120 |
Why?
|
| Interferon-gamma | 1 | 2019 | 784 | 0.120 |
Why?
|
| DNA | 3 | 2017 | 1433 | 0.120 |
Why?
|
| Aged | 11 | 2019 | 26096 | 0.110 |
Why?
|
| Protein Binding | 3 | 2016 | 2235 | 0.110 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 1995 | 12 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 589 | 0.110 |
Why?
|
| Colorado | 5 | 2022 | 4538 | 0.110 |
Why?
|
| Agricultural Workers' Diseases | 1 | 1995 | 29 | 0.110 |
Why?
|
| Presynaptic Terminals | 1 | 2016 | 89 | 0.110 |
Why?
|
| Microcephaly | 1 | 2016 | 104 | 0.110 |
Why?
|
| Cell Proliferation | 1 | 2023 | 2504 | 0.110 |
Why?
|
| Myocardium | 3 | 2005 | 931 | 0.110 |
Why?
|
| Muscle Hypotonia | 1 | 2015 | 33 | 0.110 |
Why?
|
| Brain Stem | 1 | 1995 | 98 | 0.110 |
Why?
|
| Cell Count | 2 | 2005 | 319 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 847 | 0.110 |
Why?
|
| Spleen | 4 | 2011 | 507 | 0.110 |
Why?
|
| Chikungunya virus | 1 | 2016 | 81 | 0.110 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2008 | 88 | 0.110 |
Why?
|
| Cricetinae | 3 | 2012 | 302 | 0.110 |
Why?
|
| Nerve Fibers | 1 | 1995 | 105 | 0.110 |
Why?
|
| Medulla Oblongata | 1 | 1994 | 37 | 0.110 |
Why?
|
| Demyelinating Diseases | 1 | 1995 | 84 | 0.110 |
Why?
|
| Cerebral Infarction | 1 | 1994 | 47 | 0.110 |
Why?
|
| Virus Cultivation | 1 | 2014 | 31 | 0.110 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2015 | 39 | 0.110 |
Why?
|
| West Nile Virus Vaccines | 1 | 2014 | 1 | 0.110 |
Why?
|
| Endopeptidases | 1 | 1994 | 80 | 0.110 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2014 | 6 | 0.100 |
Why?
|
| rac GTP-Binding Proteins | 2 | 2012 | 35 | 0.100 |
Why?
|
| Facial Nerve | 2 | 2007 | 39 | 0.100 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2014 | 32 | 0.100 |
Why?
|
| Microarray Analysis | 1 | 2014 | 116 | 0.100 |
Why?
|
| Hippocampus | 3 | 2005 | 969 | 0.100 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2005 | 93 | 0.100 |
Why?
|
| Bacterial Toxins | 2 | 2012 | 108 | 0.100 |
Why?
|
| Treponema pallidum | 1 | 2013 | 10 | 0.100 |
Why?
|
| Neuronal Plasticity | 1 | 2016 | 305 | 0.100 |
Why?
|
| Cryoelectron Microscopy | 2 | 2026 | 221 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2009 | 2803 | 0.100 |
Why?
|
| Epilepsy | 1 | 1998 | 390 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 3 | 2007 | 1579 | 0.100 |
Why?
|
| Tachycardia | 1 | 2013 | 57 | 0.100 |
Why?
|
| Fibroblasts | 4 | 2007 | 1022 | 0.100 |
Why?
|
| Propidium | 1 | 2013 | 8 | 0.100 |
Why?
|
| Kidney | 2 | 2011 | 1494 | 0.100 |
Why?
|
| Hydro-Lyases | 1 | 2013 | 7 | 0.100 |
Why?
|
| Cryoultramicrotomy | 1 | 2013 | 7 | 0.100 |
Why?
|
| Buffers | 1 | 2013 | 56 | 0.100 |
Why?
|
| Complement System Proteins | 1 | 2016 | 313 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2017 | 438 | 0.090 |
Why?
|
| Cerebrospinal Fluid Proteins | 2 | 2005 | 9 | 0.090 |
Why?
|
| Leukocytosis | 2 | 2005 | 32 | 0.090 |
Why?
|
| Cytochrome c Group | 2 | 2002 | 43 | 0.090 |
Why?
|
| Rats | 7 | 2012 | 5582 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 1996 | 447 | 0.090 |
Why?
|
| Infant | 6 | 2022 | 10060 | 0.090 |
Why?
|
| History, 18th Century | 2 | 2010 | 18 | 0.090 |
Why?
|
| Phagosomes | 1 | 2012 | 40 | 0.090 |
Why?
|
| Down-Regulation | 2 | 2007 | 618 | 0.090 |
Why?
|
| Myocytes, Cardiac | 2 | 2009 | 544 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 1146 | 0.090 |
Why?
|
| Cytoplasm | 1 | 2013 | 254 | 0.090 |
Why?
|
| B-Lymphocytes | 2 | 2009 | 866 | 0.090 |
Why?
|
| Etoposide | 2 | 2003 | 167 | 0.090 |
Why?
|
| Biomarkers | 2 | 2017 | 4282 | 0.090 |
Why?
|
| Genetic Techniques | 2 | 2011 | 66 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 365 | 0.090 |
Why?
|
| STAT5 Transcription Factor | 1 | 2012 | 50 | 0.090 |
Why?
|
| Glutamic Acid | 1 | 2014 | 255 | 0.090 |
Why?
|
| Fever | 1 | 2013 | 318 | 0.090 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 2 | 2002 | 31 | 0.090 |
Why?
|
| Myxovirus Resistance Proteins | 1 | 2011 | 13 | 0.090 |
Why?
|
| Immunotherapy, Adoptive | 2 | 1993 | 342 | 0.090 |
Why?
|
| Nitrendipine | 1 | 1991 | 12 | 0.080 |
Why?
|
| Cyclosporins | 1 | 1991 | 71 | 0.080 |
Why?
|
| Verapamil | 1 | 1991 | 37 | 0.080 |
Why?
|
| Histocytochemistry | 1 | 2011 | 78 | 0.080 |
Why?
|
| Cerebral Cortex | 2 | 2005 | 471 | 0.080 |
Why?
|
| Fatal Outcome | 3 | 2009 | 305 | 0.080 |
Why?
|
| GTP-Binding Proteins | 1 | 2011 | 153 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2003 | 749 | 0.080 |
Why?
|
| T-Lymphocytes | 3 | 1998 | 1993 | 0.080 |
Why?
|
| Caspases, Effector | 1 | 2010 | 2 | 0.080 |
Why?
|
| History, 17th Century | 1 | 2010 | 14 | 0.080 |
Why?
|
| Medical Illustration | 1 | 2010 | 10 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2001 | 2207 | 0.080 |
Why?
|
| Autophagy | 1 | 2012 | 288 | 0.080 |
Why?
|
| Glutamate Plasma Membrane Transport Proteins | 1 | 2009 | 7 | 0.080 |
Why?
|
| Virus Physiological Phenomena | 1 | 2009 | 9 | 0.080 |
Why?
|
| Greenhouse Effect | 1 | 2009 | 7 | 0.080 |
Why?
|
| Interferon Regulatory Factors | 1 | 2010 | 44 | 0.080 |
Why?
|
| Microscopy | 1 | 2011 | 147 | 0.070 |
Why?
|
| Animals, Wild | 1 | 2009 | 60 | 0.070 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2009 | 10 | 0.070 |
Why?
|
| Smad1 Protein | 1 | 2009 | 17 | 0.070 |
Why?
|
| Smad3 Protein | 1 | 2009 | 42 | 0.070 |
Why?
|
| Kinetics | 3 | 2005 | 1567 | 0.070 |
Why?
|
| Adolescent | 7 | 2020 | 22479 | 0.070 |
Why?
|
| United Kingdom | 2 | 2003 | 336 | 0.070 |
Why?
|
| DNA Primers | 2 | 2003 | 505 | 0.070 |
Why?
|
| Models, Biological | 3 | 2003 | 1763 | 0.070 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2009 | 25 | 0.070 |
Why?
|
| Population Surveillance | 2 | 2003 | 484 | 0.070 |
Why?
|
| Muscle, Skeletal | 2 | 2017 | 1789 | 0.070 |
Why?
|
| Mutation | 4 | 2014 | 4071 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2007 | 8318 | 0.070 |
Why?
|
| Virus Activation | 3 | 2003 | 94 | 0.070 |
Why?
|
| Epidural Space | 1 | 2008 | 17 | 0.070 |
Why?
|
| Myokymia | 1 | 2007 | 2 | 0.070 |
Why?
|
| Schizophrenia, Paranoid | 1 | 2007 | 9 | 0.070 |
Why?
|
| Reperfusion Injury | 1 | 1991 | 292 | 0.070 |
Why?
|
| STAT2 Transcription Factor | 1 | 2007 | 3 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 738 | 0.070 |
Why?
|
| Intervertebral Disc | 1 | 2008 | 36 | 0.070 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2007 | 55 | 0.060 |
Why?
|
| Bacterial Proteins | 2 | 2012 | 962 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2012 | 1706 | 0.060 |
Why?
|
| Cell Movement | 2 | 2003 | 959 | 0.060 |
Why?
|
| Morbidity | 1 | 2008 | 322 | 0.060 |
Why?
|
| Herpesvirus Vaccines | 1 | 2007 | 4 | 0.060 |
Why?
|
| Vero Cells | 3 | 2012 | 83 | 0.060 |
Why?
|
| Disease Reservoirs | 1 | 2007 | 24 | 0.060 |
Why?
|
| Herpesviridae | 1 | 2007 | 21 | 0.060 |
Why?
|
| Developing Countries | 1 | 2009 | 316 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 302 | 0.060 |
Why?
|
| Prognosis | 3 | 2019 | 4310 | 0.060 |
Why?
|
| Risk | 1 | 2009 | 916 | 0.060 |
Why?
|
| Hemagglutinins, Viral | 1 | 1986 | 8 | 0.060 |
Why?
|
| Hepatovirus | 1 | 1986 | 1 | 0.060 |
Why?
|
| Transfusion Reaction | 1 | 2007 | 61 | 0.060 |
Why?
|
| Mice, Inbred Strains | 4 | 1993 | 396 | 0.060 |
Why?
|
| Meningitis, Aseptic | 2 | 2003 | 13 | 0.060 |
Why?
|
| Disease Transmission, Infectious | 1 | 2007 | 69 | 0.060 |
Why?
|
| Virus Latency | 1 | 2007 | 90 | 0.060 |
Why?
|
| Seizures | 2 | 2008 | 482 | 0.060 |
Why?
|
| Survival Rate | 1 | 2011 | 2087 | 0.060 |
Why?
|
| Cell Division | 2 | 2000 | 753 | 0.060 |
Why?
|
| Global Health | 1 | 2009 | 403 | 0.060 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 1 | 2005 | 4 | 0.060 |
Why?
|
| Lung Transplantation | 1 | 2009 | 329 | 0.060 |
Why?
|
| Neoplasms | 1 | 2001 | 2900 | 0.060 |
Why?
|
| Retrospective Studies | 6 | 2022 | 17247 | 0.060 |
Why?
|
| Serologic Tests | 1 | 2005 | 54 | 0.060 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2005 | 49 | 0.060 |
Why?
|
| Osmolar Concentration | 1 | 2005 | 168 | 0.060 |
Why?
|
| Glutathione | 1 | 2007 | 370 | 0.060 |
Why?
|
| Interferon beta-1a | 1 | 2005 | 14 | 0.060 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2005 | 56 | 0.060 |
Why?
|
| Orthoreovirus, Avian | 1 | 2005 | 1 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 1244 | 0.060 |
Why?
|
| Risk Factors | 4 | 2009 | 10857 | 0.050 |
Why?
|
| Neurophysiology | 1 | 1984 | 13 | 0.050 |
Why?
|
| England | 2 | 2000 | 108 | 0.050 |
Why?
|
| Saimiri | 1 | 2004 | 11 | 0.050 |
Why?
|
| Analgesics | 1 | 2007 | 230 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 1043 | 0.050 |
Why?
|
| Digestive System | 1 | 2004 | 29 | 0.050 |
Why?
|
| Administration, Oral | 2 | 2004 | 862 | 0.050 |
Why?
|
| Nuclear Lamina | 1 | 2004 | 12 | 0.050 |
Why?
|
| Nuclear Localization Signals | 1 | 2004 | 16 | 0.050 |
Why?
|
| Nuclear Pore | 1 | 2004 | 19 | 0.050 |
Why?
|
| Ultraviolet Rays | 2 | 1999 | 384 | 0.050 |
Why?
|
| Serotyping | 1 | 2004 | 31 | 0.050 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2004 | 24 | 0.050 |
Why?
|
| Pancreas Transplantation | 1 | 2004 | 71 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 4 | 2013 | 5972 | 0.050 |
Why?
|
| Random Allocation | 1 | 2005 | 365 | 0.050 |
Why?
|
| Inflammation Mediators | 2 | 2021 | 506 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 2115 | 0.050 |
Why?
|
| Inclusion Bodies, Viral | 1 | 2003 | 3 | 0.050 |
Why?
|
| Retinal Ganglion Cells | 1 | 1985 | 121 | 0.050 |
Why?
|
| Vinculin | 1 | 2003 | 10 | 0.050 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2009 | 130 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 1058 | 0.050 |
Why?
|
| Thalamus | 1 | 2005 | 127 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2007 | 483 | 0.050 |
Why?
|
| Enterovirus B, Human | 1 | 2023 | 25 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2005 | 354 | 0.050 |
Why?
|
| Reflex, Stretch | 1 | 1983 | 11 | 0.050 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 2003 | 17 | 0.050 |
Why?
|
| Oxadiazoles | 1 | 2023 | 37 | 0.050 |
Why?
|
| Herpesvirus 2, Human | 1 | 2003 | 27 | 0.050 |
Why?
|
| Hepatolenticular Degeneration | 1 | 1983 | 15 | 0.050 |
Why?
|
| Oxazoles | 1 | 2023 | 48 | 0.050 |
Why?
|
| Chorea | 1 | 1983 | 13 | 0.050 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2003 | 53 | 0.050 |
Why?
|
| Pregnancy | 1 | 2016 | 7182 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 886 | 0.050 |
Why?
|
| Isoxazoles | 1 | 2023 | 55 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2004 | 428 | 0.050 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2002 | 9 | 0.050 |
Why?
|
| Luciferases | 1 | 2003 | 152 | 0.050 |
Why?
|
| Muscular Dystrophies | 1 | 1983 | 28 | 0.050 |
Why?
|
| Diagnosis, Differential | 3 | 2017 | 1506 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 5411 | 0.050 |
Why?
|
| Caspase 7 | 1 | 2002 | 22 | 0.050 |
Why?
|
| District of Columbia | 1 | 2022 | 38 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 1998 | 1261 | 0.050 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2002 | 46 | 0.050 |
Why?
|
| Tumor Virus Infections | 1 | 2002 | 50 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2002 | 115 | 0.050 |
Why?
|
| Ribavirin | 1 | 2003 | 81 | 0.050 |
Why?
|
| Liver | 1 | 2011 | 1893 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2003 | 335 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2003 | 277 | 0.050 |
Why?
|
| AIDS Dementia Complex | 1 | 2002 | 52 | 0.040 |
Why?
|
| Hemagglutinins | 1 | 2001 | 10 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 1546 | 0.040 |
Why?
|
| Junctional Adhesion Molecules | 1 | 2001 | 1 | 0.040 |
Why?
|
| Retina | 1 | 1985 | 326 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 623 | 0.040 |
Why?
|
| Transfection | 1 | 2004 | 926 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 372 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2002 | 278 | 0.040 |
Why?
|
| I-kappa B Proteins | 1 | 2002 | 75 | 0.040 |
Why?
|
| RNA, Neoplasm | 1 | 2001 | 83 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2002 | 267 | 0.040 |
Why?
|
| New York City | 1 | 2001 | 84 | 0.040 |
Why?
|
| Body Fluids | 1 | 2001 | 71 | 0.040 |
Why?
|
| Radiography | 1 | 2004 | 852 | 0.040 |
Why?
|
| Pain | 1 | 2007 | 781 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2004 | 2127 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2003 | 264 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2002 | 191 | 0.040 |
Why?
|
| Patients | 1 | 2002 | 183 | 0.040 |
Why?
|
| Lymphoma | 1 | 2002 | 233 | 0.040 |
Why?
|
| Ligands | 1 | 2003 | 664 | 0.040 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2000 | 9 | 0.040 |
Why?
|
| Creatine Kinase | 1 | 2001 | 72 | 0.040 |
Why?
|
| Electromyography | 2 | 2017 | 419 | 0.040 |
Why?
|
| Haplorhini | 1 | 2000 | 52 | 0.040 |
Why?
|
| Birds | 1 | 2001 | 86 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2005 | 892 | 0.040 |
Why?
|
| Host-Parasite Interactions | 1 | 2001 | 110 | 0.040 |
Why?
|
| Species Specificity | 2 | 1995 | 545 | 0.040 |
Why?
|
| Phenotype | 1 | 2009 | 3138 | 0.040 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2002 | 177 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2000 | 123 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2017 | 3616 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2002 | 396 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2009 | 2524 | 0.040 |
Why?
|
| Bunyamwera virus | 1 | 2019 | 3 | 0.040 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2020 | 54 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2020 | 171 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2002 | 441 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2020 | 103 | 0.040 |
Why?
|
| Recurrence | 3 | 1995 | 1134 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2001 | 396 | 0.040 |
Why?
|
| Gerstmann-Straussler-Scheinker Disease | 1 | 1999 | 1 | 0.040 |
Why?
|
| Creosote | 1 | 1999 | 3 | 0.040 |
Why?
|
| Knee Joint | 1 | 1983 | 426 | 0.040 |
Why?
|
| Antidiarrheals | 1 | 1999 | 12 | 0.040 |
Why?
|
| Muscle Weakness | 1 | 1999 | 92 | 0.040 |
Why?
|
| Acrylates | 1 | 1999 | 48 | 0.040 |
Why?
|
| Jejunum | 1 | 1999 | 37 | 0.040 |
Why?
|
| Virus Attachment | 1 | 2018 | 19 | 0.040 |
Why?
|
| Stem Cells | 1 | 2023 | 624 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2005 | 1163 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 3539 | 0.040 |
Why?
|
| A549 Cells | 1 | 2018 | 74 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2002 | 1479 | 0.030 |
Why?
|
| Age Factors | 1 | 2005 | 3338 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2004 | 698 | 0.030 |
Why?
|
| Epitopes | 2 | 1991 | 473 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2002 | 619 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2016 | 6435 | 0.030 |
Why?
|
| Vasculitis | 1 | 1998 | 69 | 0.030 |
Why?
|
| Arboviruses | 1 | 2017 | 14 | 0.030 |
Why?
|
| Antimicrobial Stewardship | 1 | 2020 | 130 | 0.030 |
Why?
|
| Neural Pathways | 1 | 1999 | 312 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2004 | 710 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 1999 | 1048 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 5886 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2000 | 534 | 0.030 |
Why?
|
| Neural Conduction | 1 | 2017 | 92 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2004 | 826 | 0.030 |
Why?
|
| Plant Extracts | 1 | 1999 | 188 | 0.030 |
Why?
|
| Atrophy | 1 | 2017 | 198 | 0.030 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2016 | 6 | 0.030 |
Why?
|
| Complement Pathway, Classical | 1 | 2016 | 17 | 0.030 |
Why?
|
| Metagenomics | 1 | 2017 | 149 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 557 | 0.030 |
Why?
|
| Spatial Memory | 1 | 2016 | 27 | 0.030 |
Why?
|
| Colon | 1 | 1999 | 308 | 0.030 |
Why?
|
| Meat Products | 1 | 1995 | 9 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 1998 | 273 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1995 | 84 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 372 | 0.030 |
Why?
|
| Food Handling | 1 | 1995 | 33 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2002 | 1442 | 0.030 |
Why?
|
| Phenylketonurias | 1 | 1995 | 15 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 1995 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1995 | 414 | 0.030 |
Why?
|
| Ammonium Chloride | 1 | 1994 | 4 | 0.030 |
Why?
|
| Chymotrypsin | 1 | 1994 | 23 | 0.030 |
Why?
|
| Cognition Disorders | 2 | 2009 | 539 | 0.030 |
Why?
|
| Necrosis | 2 | 1998 | 243 | 0.030 |
Why?
|
| Young Adult | 2 | 2022 | 14176 | 0.030 |
Why?
|
| Base Sequence | 2 | 1995 | 2168 | 0.020 |
Why?
|
| Cell Survival | 2 | 2005 | 1100 | 0.020 |
Why?
|
| Cattle | 1 | 1995 | 946 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 1993 | 60 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2019 | 873 | 0.020 |
Why?
|
| Complement Activation | 1 | 2016 | 399 | 0.020 |
Why?
|
| Co-Repressor Proteins | 1 | 2013 | 18 | 0.020 |
Why?
|
| Thymidine Kinase | 2 | 1989 | 16 | 0.020 |
Why?
|
| Syndrome | 2 | 2007 | 380 | 0.020 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2017 | 497 | 0.020 |
Why?
|
| Neuropsychological Tests | 2 | 2008 | 1134 | 0.020 |
Why?
|
| DNA Damage | 1 | 1995 | 435 | 0.020 |
Why?
|
| Trigeminal Ganglion | 2 | 1989 | 27 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2012 | 45 | 0.020 |
Why?
|
| Hemagglutination | 1 | 1991 | 7 | 0.020 |
Why?
|
| Binding Sites, Antibody | 1 | 1991 | 40 | 0.020 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1991 | 36 | 0.020 |
Why?
|
| Triterpenes | 1 | 2012 | 26 | 0.020 |
Why?
|
| Primary Cell Culture | 1 | 2012 | 172 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 1995 | 355 | 0.020 |
Why?
|
| Proteolysis | 1 | 2012 | 172 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 1991 | 70 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 104 | 0.020 |
Why?
|
| Clone Cells | 1 | 1991 | 263 | 0.020 |
Why?
|
| Diuresis | 1 | 1991 | 10 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 1991 | 137 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2022 | 5988 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 1999 | 908 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2013 | 199 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1991 | 321 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1991 | 504 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 382 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 206 | 0.020 |
Why?
|
| Antibody Formation | 1 | 1991 | 287 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 1998 | 3410 | 0.020 |
Why?
|
| Calcium Channels | 1 | 1991 | 156 | 0.020 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2009 | 8 | 0.020 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2009 | 14 | 0.020 |
Why?
|
| CD11 Antigens | 1 | 2009 | 30 | 0.020 |
Why?
|
| Trigeminal Nerve | 1 | 1989 | 27 | 0.020 |
Why?
|
| Esophagitis | 1 | 1989 | 67 | 0.020 |
Why?
|
| Paresis | 1 | 2009 | 30 | 0.020 |
Why?
|
| Precipitin Tests | 1 | 1988 | 90 | 0.020 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 1988 | 38 | 0.020 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2009 | 61 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2009 | 161 | 0.020 |
Why?
|
| Optic Neuritis | 1 | 2009 | 44 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1988 | 165 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1988 | 130 | 0.020 |
Why?
|
| Incidence | 1 | 1995 | 2915 | 0.020 |
Why?
|
| Dendrites | 1 | 2009 | 104 | 0.020 |
Why?
|
| Muscles | 1 | 1989 | 330 | 0.020 |
Why?
|
| Prospective Studies | 2 | 1998 | 8035 | 0.020 |
Why?
|
| Genetic Variation | 1 | 1993 | 967 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2008 | 35 | 0.020 |
Why?
|
| Isaacs Syndrome | 1 | 2007 | 4 | 0.020 |
Why?
|
| Skin Diseases | 1 | 2009 | 152 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2008 | 132 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1991 | 1131 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 1474 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 2007 | 72 | 0.020 |
Why?
|
| Oxidants | 1 | 2007 | 99 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 1991 | 765 | 0.020 |
Why?
|
| Superoxides | 1 | 2007 | 198 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1986 | 35 | 0.020 |
Why?
|
| Prednisone | 1 | 2007 | 221 | 0.020 |
Why?
|
| RNA, Double-Stranded | 1 | 1986 | 51 | 0.020 |
Why?
|
| Forelimb | 1 | 1986 | 44 | 0.010 |
Why?
|
| Sciatic Nerve | 1 | 1986 | 62 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 979 | 0.010 |
Why?
|
| Hindlimb | 1 | 1986 | 132 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2009 | 518 | 0.010 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2005 | 37 | 0.010 |
Why?
|
| Synapses | 1 | 2009 | 438 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2005 | 100 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 1998 | 6055 | 0.010 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2005 | 56 | 0.010 |
Why?
|
| Politics | 1 | 1986 | 92 | 0.010 |
Why?
|
| Integrins | 1 | 2005 | 90 | 0.010 |
Why?
|
| Pathology | 1 | 1984 | 21 | 0.010 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2004 | 13 | 0.010 |
Why?
|
| Muromegalovirus | 1 | 2004 | 22 | 0.010 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2004 | 36 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1991 | 1778 | 0.010 |
Why?
|
| Massachusetts | 1 | 1984 | 180 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2005 | 451 | 0.010 |
Why?
|
| Antioxidants | 1 | 2007 | 550 | 0.010 |
Why?
|
| Aphasia | 1 | 2003 | 24 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2003 | 32 | 0.010 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2003 | 35 | 0.010 |
Why?
|
| Schools, Medical | 1 | 1984 | 159 | 0.010 |
Why?
|
| Patella | 1 | 1983 | 28 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 2003 | 104 | 0.010 |
Why?
|
| Intestines | 1 | 1986 | 354 | 0.010 |
Why?
|
| Lethal Dose 50 | 1 | 2002 | 16 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 193 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2003 | 197 | 0.010 |
Why?
|
| Fluorescence | 1 | 2003 | 159 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2003 | 161 | 0.010 |
Why?
|
| Papillomaviridae | 1 | 2003 | 115 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2007 | 665 | 0.010 |
Why?
|
| Hypertrophy | 1 | 1983 | 128 | 0.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2003 | 155 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2002 | 146 | 0.010 |
Why?
|
| DNA Fingerprinting | 1 | 2002 | 28 | 0.010 |
Why?
|
| Headache | 1 | 2003 | 151 | 0.010 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2002 | 50 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 537 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2007 | 1351 | 0.010 |
Why?
|
| Liver Diseases | 1 | 2003 | 304 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2003 | 431 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2003 | 561 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2000 | 65 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2000 | 74 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 2 | 1989 | 64 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2000 | 155 | 0.010 |
Why?
|
| Ion Transport | 1 | 1999 | 62 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2000 | 391 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2004 | 917 | 0.010 |
Why?
|
| HIV Seropositivity | 1 | 1998 | 119 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 1138 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2003 | 599 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2002 | 640 | 0.010 |
Why?
|
| Diet, Protein-Restricted | 1 | 1995 | 11 | 0.010 |
Why?
|
| Phenylalanine | 1 | 1995 | 69 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1994 | 295 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 1993 | 131 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1994 | 376 | 0.010 |
Why?
|
| Amino Acids | 1 | 1995 | 519 | 0.010 |
Why?
|
| Viral Plaque Assay | 1 | 1989 | 29 | 0.000 |
Why?
|
| Restriction Mapping | 1 | 1989 | 81 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 187 | 0.000 |
Why?
|
| Genes | 1 | 1989 | 226 | 0.000 |
Why?
|
| Chromosome Deletion | 1 | 1989 | 126 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 2380 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2002 | 2662 | 0.000 |
Why?
|
| Eye | 1 | 1989 | 112 | 0.000 |
Why?
|
| Codon | 1 | 1986 | 91 | 0.000 |
Why?
|